Ari Hoffnung serves as the Chief Strategy Officer of Vireo Health. Mr. Hoffnung was previously the founder and CEO of Fiorello Pharmaceuticals, Inc., a medical cannabis company. Prior to that, Mr. Hoffnung served as New York City’s Deputy Comptroller for Budget & Public Affairs, where he oversaw the City’s $70 billion budget, managed a 100+ employee staff, and served as the chief liaison to all levels of governments and to various labor unions. Prior to serving in New York City government, Mr. Hoffnung was a Managing Director at Bear Stearns, where he worked for more than a decade. Mr. Hoffnung also led a research team composed of economists and policy experts that published two-dozen white papers, including two ground-breaking and widely-cited reports on the public-health and economic impacts of reforming cannabis policies: 100,000 Reasons: Medical Marijuana In The Big Apple and Regulating and Taxing Marijuana: The Fiscal Impact on NYC. He holds an Masters of Business Administration in Finance degree from New York University’s Stern School of Business and a Bachelor’s degree from Queens College.